GoodRx(NASDAQ) GDRX

GoodRx Holdings, Inc. helps Americans find lower prices for their medicine. It lets people compare prescription costs at nearby pharmacies for free. The company also offers paid plans and online doctor visits.

Savings at the Pharmacy Counter

• Prescription Transactions: Discount codes for medications at retail pharmacies; accounted for 53% of revenue in the three-month period ended June 30, 2026.
• Pharma Direct: Affordability programs for specific brands sponsored by pharmaceutical manufacturers; generated 31% of revenue in the three-month period ended June 30, 2026.
• Subscription Offerings: Paid plans such as Gold and Companion that provide enhanced savings on healthcare; made up 14% of revenue in the three-month period ended June 30, 2026.
• Telehealth: Affordable online medical visits for consumers seeking care or prescriptions.

Broadening the Healthcare Platform

• Acquired a prescription delivery technology business in Oct. 2025 to expand fulfillment options for consumers.
• Launched Employer Direct in the first quarter of 2026 to help businesses provide integrated cash pricing to their employees.
• Introduced GoodRx Companion in the second quarter of 2026 to offer generic medication savings and routine health services.
• Integrated with the federal TrumpRx.gov platform in Feb. 2026 to provide discounts on branded and specialty medications.

A Hub for Price Transparency

GoodRx uses direct contracts with pharmacies and partnerships with pharmacy benefit managers (PBMs) to secure lower rates. These PBMs are middleman organizations that negotiate drug prices for insurance companies and large employers.

Recent Financial Performance

• Revenue reached $200.4 million for the three-month period ended June 30, 2026, compared to $203.1 million in the same period of 2025.
• Net income was $8.5 million in the second quarter of 2026, down from $12.8 million in the second quarter of 2025.
• Pharma Direct revenue rose 76% year over year to $61.6 million during the three-month period ended June 30, 2026.
• Net cash provided by operating activities was $92.7 million for the six-month period ended June 30, 2026, up $33.7 million year over year.
• Cash and cash equivalents totaled $296.1 million as of June 30, 2026.

Adapting to a Changing Market

GoodRx is evolving from a transaction-based discount platform into a diversified provider of subscription services and manufacturer-sponsored programs. This shift helps the company adapt to retail pharmacy store closures while maintaining its mission of medication affordability.